MarketWatch

FDA approves first drug to delay the onset of congestive heart failure in dogs

The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Pharmabiz

US FDA approves Boehringer Ingelheim’s Vetmedin chewable tablets & Vetmedin solution for delay the onset of congestive heart failure in dogs

Boehringer Ingelheim, a global leader in animal health, announced that the US Food and Drug Administration (FDA) has approved Vetmedin (pimobendan) chewable tablets and Vetmedin solution (pimobendan ...
Medindia

FDA approves first drug to delay the onset of congestive heart failure in dogs

DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
Morningstar

FDA approves first drug to delay the onset of congestive heart failure in dogs

Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
AOL

US FDA approves first drug to delay heart failure in dogs

FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo Jan 19 (Reuters) - Pharmaceutical company ...